Financial Summary (All financials)
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 8.1 | 2.7 | 7.3 | 36.5 |
| Revenue growth | 198.2% | -62.7% | -80.1% | |
| Cost of goods sold | 0.8 | 0.1 | 0.3 | 24.2 |
| Gross profit | 7.3 | 2.6 | 6.9 | 12.3 |
| Gross margin | 90.0% | 95.5% | 95.6% | 33.7% |
| Research and development | 40.5 | 28.7 | 24.8 | |
| General and administrative | 13.6 | 8.8 | 10.2 | 4.8 |
| EBIT | -46.8 | -34.9 | -28.0 | -15.9 |
| EBIT margin | -580.1% | -1288.1% | -386.2% | -43.4% |
| Pre-tax income | -47.6 | -53.1 | -29.2 | -15.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -47.6 | -53.1 | -29.2 | -15.9 |
| Net margin | -589.5% | -1962.9% | -401.7% | -43.6% |
| |
| Diluted EPS | ($2.57) | ($7.42) | ($51.78) | ($36.42) |
| Shares outstanding (diluted) | 18.5 | 7.2 | 0.6 | 0.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|